BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,483,109 | -27.0% | 69,357 | -8.1% | 0.00% | -20.0% |
| Q2 2023 | $4,770,273 | +67.6% | 75,479 | +19.3% | 0.01% | +66.7% |
| Q1 2023 | $2,846,788 | +9.1% | 63,276 | +6.3% | 0.00% | 0.0% |
| Q4 2022 | $2,608,886 | -32.3% | 59,550 | +1.9% | 0.00% | -25.0% |
| Q3 2022 | $3,851,000 | +37.1% | 58,440 | +5.1% | 0.00% | +33.3% |
| Q2 2022 | $2,809,000 | -24.0% | 55,621 | -3.9% | 0.00% | 0.0% |
| Q1 2022 | $3,697,000 | -34.3% | 57,882 | +10.2% | 0.00% | 0.0% |
| Q4 2021 | $5,625,000 | +2.4% | 52,519 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $5,494,000 | +27.5% | 53,442 | +9.1% | 0.00% | +50.0% |
| Q2 2021 | $4,308,000 | -14.4% | 48,990 | -5.3% | 0.00% | -33.3% |
| Q1 2021 | $5,030,000 | -45.8% | 51,720 | -37.5% | 0.00% | -40.0% |
| Q4 2020 | $9,273,000 | +64.5% | 82,688 | +36.0% | 0.01% | +66.7% |
| Q3 2020 | $5,636,000 | -7.5% | 60,802 | -22.2% | 0.00% | -25.0% |
| Q2 2020 | $6,094,000 | +151.4% | 78,129 | +88.4% | 0.00% | +100.0% |
| Q1 2020 | $2,424,000 | -78.4% | 41,464 | -70.3% | 0.00% | -75.0% |
| Q4 2019 | $11,198,000 | +301.1% | 139,772 | +267.7% | 0.01% | +300.0% |
| Q3 2019 | $2,792,000 | -2.0% | 38,014 | +25.8% | 0.00% | -33.3% |
| Q2 2019 | $2,850,000 | -14.9% | 30,218 | -27.8% | 0.00% | 0.0% |
| Q1 2019 | $3,350,000 | +9.0% | 41,855 | -26.6% | 0.00% | -25.0% |
| Q4 2018 | $3,073,000 | -23.4% | 57,009 | +10.9% | 0.00% | 0.0% |
| Q3 2018 | $4,013,000 | +45.1% | 51,408 | +18.0% | 0.00% | +33.3% |
| Q2 2018 | $2,766,000 | -38.8% | 43,575 | -11.6% | 0.00% | -25.0% |
| Q1 2018 | $4,522,000 | +68.9% | 49,315 | +38.9% | 0.00% | +100.0% |
| Q4 2017 | $2,678,000 | -16.8% | 35,511 | -23.2% | 0.00% | -33.3% |
| Q3 2017 | $3,220,000 | +80.4% | 46,218 | +31.1% | 0.00% | +50.0% |
| Q2 2017 | $1,785,000 | +11.5% | 35,244 | -12.0% | 0.00% | +100.0% |
| Q1 2017 | $1,601,000 | +81.9% | 40,045 | +27.6% | 0.00% | 0.0% |
| Q4 2016 | $880,000 | +50.7% | 31,395 | +59.6% | 0.00% | 0.0% |
| Q3 2016 | $584,000 | +12.5% | 19,670 | -23.1% | 0.00% | 0.0% |
| Q2 2016 | $519,000 | – | 25,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |